These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 32287049)

  • 1. Identifying the Prescribing Physician in US Healthcare Claims Data.
    Der JS; Brookhart MA
    Med Care; 2020 Jun; 58(6):e39-e44. PubMed ID: 32287049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician perception of patient adherence compared to patient adherence of osteoporosis medications from pharmacy claims.
    Copher R; Buzinec P; Zarotsky V; Kazis L; Iqbal SU; Macarios D
    Curr Med Res Opin; 2010 Apr; 26(4):777-85. PubMed ID: 20095797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The medical license number accurately identifies the prescribing physician in a large pharmacy claims database.
    Brookhart MA; Avorn J; Polinksi JM; Brown TV; Mogun H; Solomon DH
    Med Care; 2007 Sep; 45(9):907-10. PubMed ID: 17712263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do physicians within the same practice setting manage osteoporosis patients similarly? Implications for implementation research.
    Curtis JR; Arora T; Xi J; Silver A; Allison JJ; Chen L; Saag KG; Schenck A; Westfall AO; Colón-Emeric C
    Osteoporos Int; 2009 Nov; 20(11):1921-7. PubMed ID: 19319619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates.
    Gu T; Eisenberg Lawrence DF; Stephenson JJ; Yu J
    Clin Interv Aging; 2016; 11():1-8. PubMed ID: 26929609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Medical Claims and Utilization of Limited Ultrasonography Among Emergency Physicians and Radiologists Within a Large Health Plan Provider.
    Bergmann KR; Reardon RF; Flores G; Whitcomb V; Christensen EW; Watson D; Kharbanda A
    J Ultrasound Med; 2019 May; 38(5):1279-1286. PubMed ID: 30208239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reasons for Not Treating Women with Postmenopausal Osteoporosis with Prescription Medications: Physicians' and Patients' Perspectives.
    Weaver JP; Olsson K; Sadasivan R; Modi A; Sen S
    J Womens Health (Larchmt); 2017 Dec; 26(12):1302-1311. PubMed ID: 28994642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of generic medication vouchers to a pharmacist academic detailing program: effects on the generic dispensing ratio in a physician-hospital organization.
    Bhargava V; Greg ME; Shields MC
    J Manag Care Pharm; 2010; 16(6):384-92. PubMed ID: 20635829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood Attention-Deficit/Hyperactivity Disorder Prescribing by Prescriber Type and Specialty in Oregon Medicaid.
    Klein TA; Panther S; Woo T; Odom-Maryon T; Daratha K
    J Child Adolesc Psychopharmacol; 2016 Aug; 26(6):548-54. PubMed ID: 27135134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the completeness of physician billing claims for diabetes case ascertainment using population-based prescription drug data.
    Lix LM; Kuwornu JP; Kroeker K; Kephart G; Sikdar KC; Smith M; Quan H
    Health Promot Chronic Dis Prev Can; 2016 Mar; 36(3):54-60. PubMed ID: 26959724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment patterns, comorbidities, healthcare resource use, and associated costs by line of chemotherapy and level of comorbidity in patients with newly-diagnosed Merkel cell carcinoma in the United States.
    Kearney M; Thokagevistk K; Boutmy E; Bharmal M
    J Med Econ; 2018 Dec; 21(12):1159-1171. PubMed ID: 30149739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying clinically questionable psychotropic prescribing practices for medicaid recipients in new york state.
    Essock SM; Covell NH; Leckman-Westin E; Lieberman JA; Sederer LI; Kealey E; Finnerty MT
    Psychiatr Serv; 2009 Dec; 60(12):1595-602. PubMed ID: 19952148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National opioid prescribing trends in emergency departments by provider type: 2005-2015.
    Yang BK; Storr CL; Trinkoff AM; Sohn M; Idzik SK; McKinnon M
    Am J Emerg Med; 2019 Aug; 37(8):1439-1445. PubMed ID: 30377010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Current State of Opioid Prescribing and Drug Enforcement Agency (DEA) Action Against Physicians: An Analysis of DEA Database 2004-2017.
    Kim DD; Sibai N
    Pain Physician; 2020 Jun; 23(3):E297-E304. PubMed ID: 32517406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. US practitioner prescribing practices and patient characteristics of those newly treated with a buprenorphine transdermal patch system.
    Pergolizzi JV; Ben-Joseph R; Chang CL; Hess G
    Curr Med Res Opin; 2014 Aug; 30(8):1579-87. PubMed ID: 24689806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of buprenorphine/naloxone prescribing: an analysis of claims data from Massachusetts.
    Paulsen R; Modestino AS; Hasan MM; Noor-E-Alam M; Young LD; Young GJ
    Am J Drug Alcohol Abuse; 2020; 46(2):216-223. PubMed ID: 31825718
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences in Opioid Prescribing Among Generalist Physicians, Nurse Practitioners, and Physician Assistants.
    Ellenbogen MI; Segal JB
    Pain Med; 2020 Jan; 21(1):76-83. PubMed ID: 30821817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-year results of a member and physician intervention to reduce risk associated with glucocorticoid-induced osteoporosis in a health plan.
    Chitre MM; Hayes W
    J Manag Care Pharm; 2008 Apr; 14(3):281-90. PubMed ID: 18439050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agreement and validity of electronic health record prescribing data relative to pharmacy claims data: A validation study from a US electronic health record database.
    Rowan CG; Flory J; Gerhard T; Cuddeback JK; Stempniewicz N; Lewis JD; Hennessy S
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):963-972. PubMed ID: 28608510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indication-Specific Opioid Prescribing for US Patients With Medicaid or Private Insurance, 2017.
    Mikosz CA; Zhang K; Haegerich T; Xu L; Losby JL; Greenspan A; Baldwin G; Dowell D
    JAMA Netw Open; 2020 May; 3(5):e204514. PubMed ID: 32391892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.